Alentis Therapeutics starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis Post published:January 4, 2022 Continue ReadingAlentis Therapeutics starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis
Alentis Therapeutics announces Board appointments Post published:November 9, 2021 Continue ReadingAlentis Therapeutics announces Board appointments
New Head of Oncology for Alentis Post published:November 1, 2021 Continue ReadingNew Head of Oncology for Alentis
New Head of Fibrosis for Alentis Post published:October 19, 2021 Continue ReadingNew Head of Fibrosis for Alentis
Alentis to Present Data at the EASL International Liver Congress 2021 Post published:June 23, 2021 Continue ReadingAlentis to Present Data at the EASL International Liver Congress 2021
Alentis Therapeutics Raises USD 67 Million in Series B Financing Post published:June 15, 2021 Continue ReadingAlentis Therapeutics Raises USD 67 Million in Series B Financing
Alentis founder receives prestigious French Academy of Science award Post published:December 23, 2020 Continue ReadingAlentis founder receives prestigious French Academy of Science award
Alentis Therapeutics Names Roberto Iacone CEO Post published:July 29, 2020 Continue ReadingAlentis Therapeutics Names Roberto Iacone CEO
ALENTIS Therapeutics launches Post published:April 30, 2019 Continue ReadingALENTIS Therapeutics launches